The extracts rich antioxidant profile may protect against this, promoting better GLP-1 activity
Additional documented interactions include the FAK-paxillin pathway, fibroblast activity, and dopaminergic, serotonergic, and GABAergic neurotransmitter systems, though these represent a more preliminary evidence base
The medication works by: Enhancing insulin secretion in a glucose-dependent manner, reducing the risk of hypoglycemia Suppressing glucagon release when blood glucose levels are elevated Slowing gastric emptying , which prolongs satiety and reduces appetite Acting on central appetite regulation in the hypothalamus to decrease food intake Zepbound is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and gradually titrated upward (5 mg, 7.5 mg, 10 mg, 12.5 mg, to a maximum of 15 mg) based on individual tolerance and therapeutic response
(PubMed) Stranges S, Marshall JR, Natarajan R, et al
Ruegsegger, G
